Category: Sterilization / Calibration
Service providers to the medical device manufacturing industry offering sterilization and calibration services.
Robert Fields, partner and managing director at Breeden Capital Management and Breeden Partners, quietly resigned from Steris Corp.'s board for personal reasons March 5.
By Mary Vanac
Robert Fields, a partner and managing director at Breeden Capital Management and Breeden Partners, quietly resigned from the Steris Corp. (NYSE:STE) board for personal reasons March 5.
Normally, the resignation of a director causes few questions. However, Fields and Richard Breeden, the former Securities and Exchange Commission chief who has since become an investment manager and shareholder activist, are a special case.
The Food & Drug Administration tells manufacturers they must revise any labeling indicating that their devices can be reprocessed using the Steris System 1 sterilization system.
The Food & Drug Administration is once again making noises about Steris Corp.'s (NYSE:STE) System 1 processor, warning endoscope manufacturers that they must change any labeling indicating that their devices can be reprocessed using the popular sterilizing device.
The Steris System 1 processor is typically used in surgical and endoscope suites for sterilizing and disinfecting medical devices.
In a letter dated Feb. 22, the FDA warned all endoscope makers that they must change the labeling on any devices that state they can be reprocessed using the Steris system and even suggested they add language indicating that "The STERIS System 1 (SS1) is not a legally marketed device."
Steris Corp. managed to post strong third-quarter results despite its imbroglio with the Food & Drug Administration, which is advising hospitals to stop using its System 1 sterilizer within 18 months.
By Mary Vanac

MENTOR, Ohio — Steris Corp. (NYSE:STE) reported higher operating profits and a modest increase in revenue for its fiscal third quarter over the year-ago quarter.
The Food & Drug Administration flexes its new muscles, forcing hospitals to stop using Steris Corp.'s endoscope sterilizer within six months.
The Food & Drug Administration told hospital administrators across the country to stop using a popular endoscope sterilizer made by Steris Corp. (NYSE:STE) within six months, after the watchdog agency could not verify the safety of the product.
The Steris System 1 processor is typically used in surgical and endoscope suites for sterilizing and disinfecting medical devices.
Product(s):
Provides a broad and integrated portfolio of laboratory and manufacturing services across the discovery-to-commercialization spectrum
Management:
Edward Hu, COO
Shuhui Chen, CSO
Suhan Tang, CMO
Xiaozhong Liu, EVP
261 Cedar Hill St, Building C
Product(s):
UV technology, surface sterilization.
Product(s):
Manufactures portable sterilization devices using chlorine dioxide gas